Almost there...

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

First Name*

Last Name*

Country*

Email*

Password* ( 6 or more alphabetic and numerical characters )

Get financial insights straight to your inbox.

YES

I have read and accept ResearchPool Terms & Conditions, and Privacy Policy, including our Cookie Use Policy

Already on ResearchPool? Login Now

Report Company Directory

Outerwall Inc

OUTFRONT COMPANIES

OUTFRONT Media Inc.

Outfront Media Inc: 1 director by SmartInsider
Global Real Estate Strategy "How global real estate is performing amid..." by UBS AG
U.S. REITs "Crowded Stocks: What the Quant Data Says About REITs, May..." by UBS AG
The Financial Espresso "PagBank PIX NFC; MELI investment in marketing;..." by UBS AG
OUTsurance Group "Stars aligning, particularly in Australia" (Neutral) by UBS AG
South African Financials "Crowding among SA Financials" Christelis by UBS AG
South African Financials "Views on the ground - Investor questions from..." by UBS AG
South African Insurance Sector "June 2024 Market Share Monitor" Christelis by UBS AG
OUTsurance Group "Stronger growth for longer [Erratum]" (Neutral) Christelis by UBS AG
First Read: OUTsurance Group "H2 claims beat; outlook mixed" (Neutral) by UBS AG

OUTFRONT MEDIA INC.

South African Insurance Sector "More normalised rainfall in SA in May"... by UBS AG
South African Financials "Crowding among SA Financials" Christelis by UBS AG
South African Insurance Sector "Some wetter weather persists into April"... by UBS AG
South African Insurance Sector "Views from the road" Christelis by UBS AG
OUTsurance Group "Earnings Outlook: EPS CAGR Remains Steady at 15%" (Neutral) by UBS AG
South African Insurance Sector "December 2024 Market Share Monitor" Christelis by UBS AG
South African Financials "Crowding among SA Financials" Christelis by UBS AG
First Read: OUTsurance Group "Exceptional underwriting conditions offset..." by UBS AG
South African Insurance Sector "Key expectations ahead of results" Christelis by UBS AG
South African Financials "Crowding among SA Financials" Christelis by UBS AG

OUTIN FUTURES CO LTD

Outlook Therapeutics

Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event by GlobeNewsWire
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD by GlobeNewsWire
Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD by GlobeNewsWire
Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering by GlobeNewsWire
Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants by GlobeNewsWire
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update by GlobeNewsWire
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD by GlobeNewsWire
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration by GlobeNewsWire
Outlook Therapeutics® Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference by GlobeNewsWire
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update by GlobeNewsWire

Outlook Therapeutics

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Report Company Directory

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe